Physician

Aimee F Luat, M.D.

According to 2025 Medicare claims, Aimee Luat, M.D. (NPI: 1326216821) practices neurology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is UNIVERSITY PEDIATRICIANS (NPI: 1811920549; TIN: 383336414) and primary practice location at 48201-9998.

Luat's data goes back to 2015 and runs through 2024. Part D data shows 246 prescription claims across 11 beneficiaries totaling $214,943 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). Open Payments data shows 23 records totaling $49,473. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $241 to $214,943. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	12	$241
2016	N/R	N/R	N/R
2017	N/R	56	$32,378
2018	N/R	72	$61,918
2019	N/R	180	$119,381
2020	N/R	127	$114,189
2021	N/R	132	$131,740
2022	N/R	132	$117,260
2023	N/R	227	$301,355
2024	11	246	$214,943

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	31	898	$133,995
Vimpat	Lacosamide	19	419	$26,753
Fycompa	Perampanel	13	351	$13,498
Clobazam	Clobazam	30	942	$2,469
Lacosamide	Lacosamide	26	780	$1,852

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$1,662	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$47,811	Marinus Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aimee F. Luat, M.D.?

Tedicare shows public-source Medicare data for Aimee F. Luat, M.D. (NPI 1326216821), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aimee F. Luat, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aimee F. Luat, M.D.?

Aimee F. Luat, M.D. is linked to UNIVERSITY PEDIATRICIANS (billing NPI 1811920549) in the available physician profile data.

Does Aimee F. Luat, M.D. have Open Payments data?

Aimee F. Luat, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.